Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review

Y Farsi, A Tahvildari, M Arbabi, F Vazife… - Frontiers in cellular …, 2022 - frontiersin.org
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic caused by Severe Acute
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …

The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis

HS Bozkurt, EMM Quigley - International Journal of …, 2020 - journals.sagepub.com
COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also
lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically …

A synbiotic combination of Bifidobacterium longum Bif10 and Bifidobacterium breve Bif11, isomaltooligosaccharides and finger millet arabinoxylan prevents dextran …

S Sharma, R Bhatia, K Devi, A Rawat, S Singh… - International Journal of …, 2023 - Elsevier
Decreased bifidobacterial abundance, disrupted gut barrier function, dysregulated immune
response and ulceration have been reported in the gut microbiota of IBD patients. Non …

Oral booster probiotic bifidobacteria in SARS-COV-2 patients

HS Bozkurt, Ö Bilen - International journal of …, 2021 - journals.sagepub.com
Oral booster-single strain probiotic bifidobacteria could be a potential strategy for SARS-
CoV-2. This study aims to evaluate the role of oral probiotic Bifidobacterium on …

Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease …

L Qiu, R Shen, L Wei, S Xu, W Xia, Y Hou, J Cui… - Journal of …, 2023 - Springer
Patients with inflammatory bowel disease (IBD) always suffer from severe abdominal pain
and appear to be at high risk for colorectal cancer. Recently, the co-delivery of targeted …

[HTML][HTML] Inflammatory bowel disease-A peek into the bacterial community shift and algae-based 'biotic'approach to combat the disease

V Kiron, M Hayes, D Avni - Trends in Food Science & Technology, 2022 - Elsevier
Background Inflammatory bowel disease (IBD) was regarded as a problem of the
industrialised nations. However, with the popularity and convenience connected to ultra …

[HTML][HTML] Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future

C Vigano, G Mulinacci, A Palermo… - World journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); since its first …

A review of xyloglucan: Self-aggregation, hydrogel formation, mucoadhesion and uses in medical devices

J Esquena-Moret - Macromol, 2022 - mdpi.com
The present paper reviews the self-aggregation, gel-forming and adsorption properties of
xyloglucan (XG), and its main applications as a medical device for wound dressings …

The role of purported mucoprotectants in dealing with irritable bowel syndrome, functional diarrhea, and other chronic diarrheal disorders in adults

C Alonso-Cotoner, M Abril-Gil, M Albert-Bayo… - Advances in …, 2021 - Springer
Chronic diarrhea is a frequent presenting symptom, both in primary care medicine and in
specialized gastroenterology units. It is estimated that more than 5% of the global population …

[HTML][HTML] Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss

YL Zhang, Q Chen, L Zheng, ZW Zhang… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Bone loss and osteoporosis are commonly described as extra-intestinal
manifestations of inflammatory bowel disease (IBD). Jianpi Qingchang Bushen decoction …